Cadila Healthcare Limited has informed the Exchange regarding a press release dated April 23, 2021, titled "Zydus receives Emergency Use Approval from DCGI for the use of Pegylated Interferon alpha-2b, Virafin in treating moderate COVID-19 infection in adults".